IP Library Granted Patent US 7,255,881
Granted Patent B2
US 7,255,881 · App. 10/690,774 · Granted Aug 14, 2007

Metal-containing materials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,255,881
App. No.
10/690,774
Granted
Aug 14, 2007
Kind
B2
Abstract

Metal-containing materials, as well as their preparation and use are disclosed. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, anti-proliferative, MMP modulating material, an atomically disordered, crystalline material, and/or a nanocrystalline material. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.

Claims (8)

1. An article in suppository form, comprising:

an atomically disordered, nanocrystalline material comprising a metal and an element, wherein the metal is selected from the group consisting of silver, gold, platinum, palladium and combinations thereof, and the element is selected from the group consisting of oxygen, nitrogen, carbon, boron, sulfur, phosphorus, silicon, a halogen, hydrogen and combinations thereof,

wherein the atomically disordered, nanocrystalline material contains at least about one atomicpercent of the element and the article contains a pharmaceutically acceptable carrier.

2. The article of claim 1 , wherein the nanocrystalline material comprises at most about 90 weight percent of the element.

3. The article of claim 1 , wherein the nanocrystalline material is in the form of an agglomerate of clusters of atoms.

4. The article of claim 1 , wherein the nanocrystalline material comprises a material selected from the group consisting of antimicrobial materials, antibacterial materials, anti-inflammatory materials, antifungal materials, antiviral materials, anti-autoimmune materials, anti-cancer materials, pro-apoptosis materials, MMP modulating materials, anti-proliferative materials, and combinations thereof.

5. The article of claim 1 , wherein the metal is silver.

6. The article of claim 1 , wherein the atomically disordered, nanocrystalline material contains a combination of metals selected from the group consisting of silver, gold, platinum and palladium.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2004
From: GILLIS, SCOTT H.; SCHECHTER, PAUL; STILES, JAMES
To: NUCRYST PHARMACEUTICALS CORP.
Reel/Frame 015122/0904 →